Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely melatonin 2 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Prolonged-release film-coated oral tablet (dose form) |
Is a |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Gastro-resistant and prolonged-release oral tablet |
Is a |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Paliperidone 3 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Quetiapine (as quetiapine fumarate) 300 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Nicotinic acid 250 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Paliperidone 6 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Quetiapine (as quetiapine fumarate) 200 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely quetiapine (as quetiapine fumarate) 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely zileuton 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Paliperidone 9 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely bupropion hydrobromide 174 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely bupropion hydrobromide 348 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely bupropion hydrobromide 522 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
amoxicillin 775 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Ropinirole (as ropinirole hydrochloride) 4 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Ropinirole (as ropinirole hydrochloride) 8 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
ropinirol 3 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely levetiracetam 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Potassium chloride 1.5 g prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely paliperidone 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
guanfacinhydrokorid 4 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
guanfacinhydrokorid 3 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
guanfacinhydrokorid 1 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
guanfacinhydrokorid 2 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
pramipexoldihydroklorid 3 milligram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
pramipexoldihydroklorid 4,5 milligram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely trazodone hydrochloride 300 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely fampridine 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
pramipexoldihydroklorid 375 mikrogram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Trazodone hydrochloride 150 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
pramipexoldihydroklorid 1,5 milligram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
pramipexoldihydroklorid 750 mikrogram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Nevirapine 400 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Conventional release and prolonged-release oral tablet |
Is a |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Alfuzosin hydrochloride 10 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
metylfenidathydroklorid 72 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Salbutamol (as salbutamol sulfate) 8 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely nicotinic acid 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
cetirizinhydroklorid 5 mg + pseudoefedrin 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 20 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
furosemid 40 mg + kalium 8 mmol, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
tamsulosinhydroklorid 400 mikrogram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Oxycodone hydrochloride 80 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
takrolimus 4 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely procainamide hydrochloride 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
teofyllin 500 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Diltiazem hydrochloride 120 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
cefaklor (som cefaklormonohydrat) 375 milligram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
metoprololtartrat 200 milligram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely morphine sulfate 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
fexofenadinhydroklorid 180 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely sodium chloride 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Disopyramide (as disopyramide phosphate) 250 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely theophylline 250 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
guajfenesin 1 200 mg + pseudoefedrin 120 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
järn(II)sulfat 325 mg + folsyra 350 mikrogram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely salbutamol (as salbutamol sulfate) 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Theophylline 200 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
isosorbidmononitrat 30 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Clarithromycin 500 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely methylphenidate hydrochloride 18 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
lovastatin 20 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
karbidopa (som karbidopamonohydrat) 25 milligram och levodopa 100 milligram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
glipizid 5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Procainamide hydrochloride 500 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Morphine sulfate 30 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
dietylpropionhydroklorid 75 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely bupropion hydrochloride 150 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely clarithromycin 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Tramadol hydrochloride 100 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely indapamide 1.5 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
glipizid 2,5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely etodolac 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely quinidine bisulfate 250 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Tramadol hydrochloride 150 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
litiumkarbonat 300 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
vattenfritt teofyllin 100 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
karbamazepin 100 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely theophylline 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely diclofenac sodium 100 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
oximorfon 5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely clomipramine hydrochloride 75 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
cefaklor 500 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
järn(II)sulfat 160 mg + folsyra 400 mikrogram, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
guajfenesin 1 200 mg + dextrometorfan 60 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
furosemid 20 mg + kalium 10 mmol, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely isosorbide mononitrate 25 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
enalaprilmaleat 5 mg + felodipin 2,5 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Tramadol hydrochloride 300 mg prolonged-release oral tablet |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
etodolak 400 mg, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
kaliumklorid 10 milliekvivalenter, depåtablett |
Has manufactured dose form |
False |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|
Product containing precisely nifedipine 10 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has manufactured dose form |
True |
Prolonged-release oral tablet |
Inferred relationship |
Some |
|